Certified by Founder Lodge
Parker Institute for Cancer Immunotherapy
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $75,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy b
| Company | Date | Round | Raised |
|---|---|---|---|
 Georgiamune Inc. |
August, 10 ,2023 | Series A | $75,000,000 |
Knit
CHARM Therapeutics
Curebase
SLAMcore Limited
Anthropic
Foreverland Food | $6,956,279 | (Mar 24, 2026)
Flourish Care | $5,700,000 | (Mar 24, 2026)
Meadow Memorials | $9,000,000 | (Mar 24, 2026)
CisLunar Industries | $2,600,000 | (Mar 24, 2026)
Oryon Cell Therapies | $21,000,000 | (Mar 24, 2026)
